BIO Deutschland’s chairman of the board receives delegation from Beijing’s CR Life Science Group

Peter Heinrich, chairman of the board of BIO Deutschland, hosted a visit by the Beijing-based CR Life Science Group at the premises of BioM’s Munich Biotech Cluster. The objective of the visit was not only to introduce the work of BIO Deutschland, but also, more importantly, to discuss the advantages Germany offers as a location for biotechnology and to call attention to investment opportunities. CR Life Science Group includes CR Life Science Park in Beijing and CR Life Science Pharma, China’s second largest pharmaceutical company, as well as CR-CP Life Science Fund, which invests internationally.